Simvastatin inhibited the apoptosis of PC12 cells induced by 1-methyl-4-phenylpyridinium ion via inhibiting reactive oxygen species production

Cell Mol Neurobiol. 2013 Jan;33(1):69-73. doi: 10.1007/s10571-012-9872-9. Epub 2012 Aug 7.

Abstract

In the present study, we investigated the neuroprotection of simvastatin in PC12 cells following 1-methyl-4-phenylpyridinium ion (MPP+) neurotoxicity. Simvastatin inhibited the decrease of cell viability induced by MPP+ in PC12 cells. The damage of PC12 cells in morphology was alleviated and the apoptotic rates were decreased due to simvatatin pretreatment against MPP+ cytotoxicity. The reactive oxygen species production exposure to MPP+ was inhibited by simvatatin in PC12 cells. So simvastatin may be of therapeutic benefit for PD patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenylpyridinium / antagonists & inhibitors
  • 1-Methyl-4-phenylpyridinium / toxicity*
  • Animals
  • Apoptosis / drug effects*
  • Apoptosis / physiology
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Neuroprotective Agents / pharmacology*
  • PC12 Cells
  • Rats
  • Reactive Oxygen Species / antagonists & inhibitors*
  • Reactive Oxygen Species / metabolism
  • Simvastatin / pharmacology*

Substances

  • Neuroprotective Agents
  • Reactive Oxygen Species
  • Simvastatin
  • 1-Methyl-4-phenylpyridinium